Martin L. Bryant
- Epidemiology top 2%
- Molecular Biology top 10%
- Virology top 0.5%
- Infectious Diseases top 1%
- Immunology top 5%
- Co-authors
- Lee RatnerRichard A. LernerFred C. JensenJohn H. ElderH. F. MaassabMurray B. GardnerPreston A. MarxPaul A. Luciw
- Topics
- HIV/AIDS drug development and treatment (23 papers)HIV Research and Treatment (19 papers)T-cell and Retrovirus Studies (6 papers)
- Partner nations
- United StatesFrancePuerto Rico
In The Last Decade
Martin L. Bryant
48 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Epidemiology 1.3k
- Molecular Biology 1.0k
- Virology 1.0k
- Infectious Diseases 1.0k
- Immunology 596
Countries citing papers authored by Martin L. Bryant
This map shows the geographic impact of Martin L. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin L. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin L. Bryant more than expected).
Fields of papers citing papers by Martin L. Bryant
This network shows the impact of papers produced by Martin L. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin L. Bryant. The network helps show where Martin L. Bryant may publish in the future.
Co-authorship network of co-authors of Martin L. Bryant
This figure shows the co-authorship network connecting the top 25 collaborators of Martin L. Bryant. A scholar is included among the top collaborators of Martin L. Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin L. Bryant. Martin L. Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 6 | |
| 3 | 23 | |
| 4 | 102 | |
| 5 | 208 | |
| 6 | 86 | |
| 7 | 62 | |
| 8 | 46 | |
| 9 | 32 | |
| 10 | 37 | |
| 11 | 22 | |
| 12 | 24 | |
| 13 | 8 | |
| 14 | 153 | |
| 15 | 8 | |
| 16 | 100 | |
| 17 | 33 | |
| 18 | 39 | |
| 19 | 16 | |
| 20 | 8 |
About Martin L. Bryant
Martin L. Bryant is a scholar working on Virology, Infectious Diseases and Immunology, having authored 48 papers that have together received 3.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (19 papers) and T-cell and Retrovirus Studies (6 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (1.0k citations) and Epidemiology (1.3k citations). Martin L. Bryant has collaborated with scholars based in United States, France and Puerto Rico. Frequent co-authors include Lee Ratner, Richard A. Lerner, Fred C. Jensen, John H. Elder, H. F. Maassab, Murray B. Gardner, Preston A. Marx, Paul A. Luciw, Michael D. Power and Philip J. Barr. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.